Author: Michelle Mitchell

For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them.

By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires?

Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer.

As the Conservative leadership campaign continues towards its finale, our next Prime Minister must make cancer a priority

We are launching a new strategy to help us make new discoveries and bring about a world where everyone lives longer, better lives, free from the fear of cancer.

We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan.

This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve.

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK’s CEO, Michelle Mitchell, knows that it requires real investment.

We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.